American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

December 27, 2019

Newsletter Sponsor

eBook: Optimizing Pharmaceutical Product Development

Developing drug products is a progressively competitive, expensive and high-risk venture that when successful, can bring considerable humanitarian and financial reward. Malvern Panalytical’s unique range of physicochemical analysis techniques can be used to accelerate the development of pharmaceutical formulations, enabling critical material attributes such as particle size, shape, structure and composition to be measured, aiding reference listed drug (RLD) deformulation, helping establish bioequivalence in vitro, and accelerating formulation development efficiency for both innovator and generic products.

	Industry News

FDA Approves New Treatment for Adults with Migraine
The FDA approved Ubrelvy tablets for the acute treatment of migraine with or without aura in adults. read more »

Sangamo Announces Early Completion of Transfer to Pfizer of SB-525
Sangamo announced the completion of the transfer to Pfizer of the SB-525 Hemophilia A gene therapy ... read more »

Phathom Announces Initiation of Trial for Vonoprazan
Phathom announced the initiation of PHALCON-HP. read more »

FDA Grants Avatrombopag Orphan Drug Designation
Dova has been granted ODD by the FDA for avatrombopag for the potential treament of Chemotherapy-... read more »

Diversey Acquires AHP® Intellectual Property from Virox Technologies
Diversey announced the acquisition of the global intellectual property rights related to AHP®, a ... read more »

FDA approves first generics of Eliquis
The FDA has approved two applications for the first generics of Eliquis tablets to reduce the risk ... read more »

	Featured Articles

Analysis of FDA Enforcement Reports (2012-2019) to Determine the Microbial Diversity in Contaminated Non-Sterile and Sterile Drugs An analysis of FDA enforcement reports from 2012 to 2019 showed that Gram-negative bacteria were the... read more »

Clinical Evidence for the Suitability of Current Bacterial Endotoxin Testing Over the last three decades, the sciences of immunology and cell biology have been revolutionized by... read more »

	Featured Video

Watch Video: Sartorius - Science on Tap
Watch Video: Sartorius - Science on Tap read more »

On-Demand Webinar: The Status of Recombinant Reagents Used for Bacterial Endotoxin Testing (BET)
In this webinar you’ll learn about the current status of the recombinant reagents on the global market, proposed changes to USP <85> and specific examples... read more »

	Featured Products

Accucore Solid Core Columns
read more »

Parteck LUB STA 50 Vegetable Grade Stearic Acid 50
read more »

	Featured Whitepaper

Automated Endotoxin Testing: ENDOZYME® II GO Recombinant Factor C Assay and the ASSIST PLUS Pipetting Robot
The ENDOZYME® II GO rFC assay was recently introduced by bioMérieux, featuring a novel 96-well microplate, GOPLATE™, reducing manual handling and enabling a higher degree of consistency. read more »

An Update for Pharmaceutical Stress Testing Enabled by Modern Informatics Technologies
Stress testing or forced degradation is a fundamental part of drug development, specifically related to purity through control of stability. read more »

	Events

Best Practices for Aseptic Sampling from Stainless Process Equipment
Online – 01/23/2020
In this webinar we’ll review the pros and cons of common sampling methodologies and best practices for choosing the most appropriate sample collection... event details »

CPhI Japan
Osaka, Japan – 09/30/2020
CPhI Japan is the ideal business platform for international pharma professionals to join in order to grow business in the rapidly changing Japanese ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA